Analyst Viewpoint
Expansion in animal feed sector and rise in production of vaccines and immunoglobulins are propelling the bovine blood plasma derivatives market size. Bovine blood products are gaining traction in the food & beverage sector for the production of various functional foods and dietary supplements. They are also widely employed in the R&D of various diagnostic tests.
Thrombin derivatives are gaining popularity in vitro studies, coagulation research, protein structure analysis, medical research, and biochemical research, whereas bovine-derived albumins are being widely used in the production of several vaccines. Major vendors in the industry are adopting M&A strategies to strengthen their product portfolio and increase their bovine blood plasma derivatives market share.
Bovine blood plasma derivatives are products derived from the blood of cattle. These derivatives are used in various applications such as food processing, biopharmaceuticals, and animal feed. Immunoglobulin, fibrinogen, bovine serum albumin, fetal bovine serum, thrombin, transferrin, and newborn calf serum are various types of bovine blood plasma derivatives. Bovine immunoglobulin G (IgG) is one of the most common commercially available bovine-derived protein fractions.
Bovine blood plasma protein extraction involves the use of a chromatographic extraction process that does not involve the use of heat, organic solvents, or stabilizers. Bovine serum derivatives are in high demand across various end-use industries such as nutrition supplements, diagnostics, pharmaceuticals, biotechnology, cosmetics, and food & beverage. These derivatives are considered a rich protein source.
Bovine blood-derived proteins are used in the production of plasma powder that are highly digestible animal protein sources used to improve feed palatability and gut health in animals. Spray-dried plasma proteins are a good protein source for dairy cows. These proteins help improve milk production significantly without affecting cow’s reproductive performance and health. Spray-dried bovine plasma and hydrolyzed spray-dried bovine plasma sources also aid in increasing pig growth performance and reduce diarrhea in the post-weaning period.
Growth in the animal feed sector is propelling the bovine blood plasma derivatives market development. According to an Institute for Feed Education and Research (IFEEDER) study, pets and domestic livestock in the U.S. consumed approximately 284 million tons of animal food in 2019. The top three feed consumers included beef cattle at 64.5 million tons, hogs at 61.8 million tons, and broiler chickens at 60.8 million tons. Moreover, rise in number of animal feedstock is expected to spur the bovine blood plasma derivatives industry growth in the near future. According to Alltech's 2021 Global Feed Survey, global animal feed production increased 1% in 2020 to 1,187.7 million metric tons.
Major companies in the food & beverage industry are launching new functional foods and dietary supplements. They are incorporating blood plasma derivatives to advance the nutritional values of their products. Blood proteins show good functional properties making them suitable for use in processed food for human consumption. Recent advancements in blood collection and processing techniques have led to a surge in the adoption of blood protein ingredients in foods and dietary supplements. Plasma proteins can be very effective low-cost alternatives for replacing eggs in baked goods. Blood proteins provide an economic and readily available alternative source of proteins and irons for use in foods and dietary supplements. Thus, surge in demand for functional foods and dietary supplements is augmenting the bovine blood plasma derivatives market progress.
Immunoglobulins can be employed in the treatment and management of various gastrointestinal diseases. Various studies have demonstrated the effectiveness of serum-derived bovine immunoglobulin/protein isolate in reducing diarrhea and restoring the ability of the gastrointestinal tract to properly absorb and utilize nutrients. Bovine immunoglobulins can also be used for passive immunization in humans. These immunoglobulins can also be incorporated into vaccines designed for specific pathogens, providing a targeted approach to disease prevention.
Bovine blood plasma derivatives are gaining traction in the R&D of various diagnostic tests. Thrombin is gaining popularity across the healthcare sector as it is widely used in various diagnostic procedures and surgeries. It is often used in conjunction with other hemostatic aids, including absorbable agents, and with fibrinogen in fibrin glues. Bovine blood plasma derivatives find extensive applications in various research activities including coagulation research, vitro study, medical research, biochemical research, and protein structure analysis. Hence, R&D of diagnostic tests is fueling the bovine blood plasma derivatives market landscape.
According to the latest bovine blood plasma derivatives market trends, the thrombin derivative type segment is projected to hold largest share during the forecast period. Growth of the segment can be ascribed to increase in usage of thrombin during surgeries and diagnostic purposes. R&D applications of thrombin include in vitro studies, coagulation research, protein structure analysis, medical research, and biochemical research.
According to the latest bovine blood plasma derivatives market research, the bovine serum albumin segment is expected to maintain its position as the second leading segment in the near future. Bovine serum albumin is widely employed in the food sector, drug formulation, and as a component of media for cell culture. Bovine-derived albumins are used in the production of several vaccines. They are utilized as a standard for protein concentrations (Bradford protein assay) in cell culture protocols.
According to the latest bovine blood plasma derivatives market analysis, North America held largest share in 2022, followed by Asia Pacific. High demand for pharmaceuticals and biotechnology products is driving the market dynamics in North America. Research and development activities related to medical products and biotechnology are also boosting the demand for bovine blood plasma derivatives in the region.
Growth in animal husbandry sector is propelling the bovine blood plasma derivatives market statistics in Asia Pacific. The total meat production in India was 9.29 million tons in 2022, an increase of 5.62% as compared to 2021, according to the ‘Basic Animal Husbandry Statistics,’ prepared by the Ministry of Fisheries, Animal Husbandry & Dairying, Government of India. Moreover, India continued to remain the largest milk-producing country in the world. The production increased by 5.29% in 2022 over the previous year.
Most blood plasma derivative companies are acquiring other globally recognized biotechnology businesses to strengthen their product portfolio. Some of the key bovine blood plasma derivative manufacturers include Merck KGaA, LAMPIRE Biological Laboratories, Inc., Proliant Health & Biologicals, Rocky Mountain Biologicals, Bovogen Biologicals Pty Ltd., Thermo Fisher Scientific, Inc., Kraeber & Co GmbH, Auckland BioSciences Ltd., and Lake Immunogenics, Inc.
These companies have been profiled in the bovine blood plasma derivatives market report based on parameters, such as business strategies, financial overview, product portfolio, company overview, recent developments, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 1.9 Bn |
| Market Forecast (Value) in 2031 | US$ 3.2 Bn |
| Growth Rate (CAGR) | 5.7% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2021 |
| Quantitative Tons | US$ Bn for Value and Kilograms for Volume |
| Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
It was valued at US$ 1.9 Bn in 2022
It is projected to grow at a CAGR of 5.7% from 2023 to 2031
Expansion in animal feed sector and rise in production of vaccines and immunoglobulins
The thrombin derivative type segment held the largest share in 2022
North America was the most lucrative region in 2022
Merck KGaA, LAMPIRE Biological Laboratories, Inc., Proliant Health & Biologicals, Rocky Mountain Biologicals, Bovogen Biologicals Pty Ltd., Thermo Fisher Scientific, Inc., Kraeber & Co GmbH, Auckland BioSciences Ltd., and Lake Immunogenics, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bovine Blood Plasma Derivatives Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Derivative Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Derivative Type, 2017–2031
6.3.1. Immunoglobulin
6.3.2. Fibrinogen
6.3.3. Bovine Serum Albumin
6.3.4. Fetal Bovine Serum
6.3.5. Thrombin
6.3.6. Transferrin
6.3.7. Newborn Calf Serum
6.3.8. Others
6.4. Market Attractiveness Analysis, by Derivative Type
7. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Pharmaceutical Industry
7.3.2. Diagnostics Industry
7.3.3. Cell Culture/ Biotechnology
7.3.4. Research and Development
7.3.5. Food Industry
7.3.6. Cosmetic Industry
7.3.7. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2017–2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Bovine Blood Plasma Derivatives Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Derivative Type, 2017–2031
9.3.1. Immunoglobulin
9.3.2. Fibrinogen
9.3.3. Bovine Serum Albumin
9.3.4. Fetal Bovine Serum
9.3.5. Thrombin
9.3.6. Transferrin
9.3.7. Newborn Calf Serum
9.3.8. Others
9.4. Market Value Forecast, by Application, 2017–2031
9.4.1. Pharmaceutical Industry
9.4.2. Diagnostics Industry
9.4.3. Cell Culture/ Biotechnology
9.4.4. Research and Development
9.4.5. Food Industry
9.4.6. Cosmetic Industry
9.4.7. Others
9.5. Market Value Forecast, by Country, 2017–2031
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Derivative Type
9.6.2. By Application
9.6.3. By Country
10. Europe Bovine Blood Plasma Derivatives Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Derivative Type, 2017–2031
10.3.1. Immunoglobulin
10.3.2. Fibrinogen
10.3.3. Bovine Serum Albumin
10.3.4. Fetal Bovine Serum
10.3.5. Thrombin
10.3.6. Transferrin
10.3.7. Newborn Calf Serum
10.3.8. Others
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Pharmaceutical Industry
10.4.2. Diagnostics Industry
10.4.3. Cell Culture/ Biotechnology
10.4.4. Research and Development
10.4.5. Food Industry
10.4.6. Cosmetic Industry
10.4.7. Others
10.5. Market Value Forecast, by Country/Sub-region, 2017–2031
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Derivative Type
10.6.2. By Application
10.6.3. By Country/Sub-region
11. Asia Pacific Bovine Blood Plasma Derivatives Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Derivative Type, 2017–2031
11.3.1. Immunoglobulin
11.3.2. Fibrinogen
11.3.3. Bovine Serum Albumin
11.3.4. Fetal Bovine Serum
11.3.5. Thrombin
11.3.6. Transferrin
11.3.7. Newborn Calf Serum
11.3.8. Others
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Pharmaceutical Industry
11.4.2. Diagnostics Industry
11.4.3. Cell Culture/ Biotechnology
11.4.4. Research and Development
11.4.5. Food Industry
11.4.6. Cosmetic Industry
11.4.7. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Derivative Type
11.6.2. By Application
11.6.3. By Country/Sub-region
12. Latin America Bovine Blood Plasma Derivatives Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Derivative Type, 2017–2031
12.3.1. Immunoglobulin
12.3.2. Fibrinogen
12.3.3. Bovine Serum Albumin
12.3.4. Fetal Bovine Serum
12.3.5. Thrombin
12.3.6. Transferrin
12.3.7. Newborn Calf Serum
12.3.8. Others
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Pharmaceutical Industry
12.4.2. Diagnostics Industry
12.4.3. Cell Culture/ Biotechnology
12.4.4. Research and Development
12.4.5. Food Industry
12.4.6. Cosmetic Industry
12.4.7. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Derivative Type
12.6.2. By Application
12.6.3. By Country/Sub-region
13. Middle East & Africa Bovine Blood Plasma Derivatives Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Derivative Type, 2017–2031
13.3.1. Immunoglobulin
13.3.2. Fibrinogen
13.3.3. Bovine Serum Albumin
13.3.4. Fetal Bovine Serum
13.3.5. Thrombin
13.3.6. Transferrin
13.3.7. Newborn Calf Serum
13.3.8. Others
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Pharmaceutical Industry
13.4.2. Diagnostics Industry
13.4.3. Cell Culture/ Biotechnology
13.4.4. Research and Development
13.4.5. Food Industry
13.4.6. Cosmetic Industry
13.4.7. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Derivative Type
13.6.2. By Application
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Merck KGaA
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. LAMPIRE Biological Laboratories, Inc.
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. Proliant Health & Biologicals
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. Rocky Mountain Biologicals
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Bovogen Biologicals Pty Ltd.
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Thermo Fisher Scientific, Inc.
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. Kraeber & Co GmbH
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. Auckland BioSciences Ltd.
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
14.3.9. Lake Immunogenics, Inc.
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Financial Overview
14.3.9.5. Strategic Overview
List of Tables
Table 01: Global Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Derivative Type, 2017–2031
Table 02: Global Africa Bovine Blood Plasma Derivatives Market Volume (Kilograms) Forecast, by Derivative Type, 2017–2031
Table 03: Global Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 04: Global Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 05: Global Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Derivative Type, 2017–2031
Table 07: North America Africa Bovine Blood Plasma Derivatives Market Volume (Kilograms) Forecast, by Derivative Type, 2017–2031
Table 08: North America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 09: North America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 10: North America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 11: Europe Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Derivative Type, 2017–2031
Table 12: Europe Africa Bovine Blood Plasma Derivatives Market Volume (Kilograms) Forecast, by Derivative Type, 2017–2031
Table 13: Europe Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 14: Europe Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 15: Europe Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 16: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Derivative Type, 2017–2031
Table 17: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Volume (Kilograms) Forecast, by Derivative Type, 2017–2031
Table 18: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 19: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 21: Latin America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Derivative Type, 2017–2031
Table 22: Latin America Africa Bovine Blood Plasma Derivatives Market Volume (Kilograms) Forecast, by Derivative Type, 2017–2031
Table 23: Latin America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Latin America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 25: Latin America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Derivative Type, 2017–2031
Table 27: Middle East & Africa Bovine Blood Plasma Derivatives Market Volume (Kilograms) Forecast, by Derivative Type, 2017–2031
Table 28: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 29: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 30: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
List of Figures
Figure 01: Global Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Derivative Type, 2022 and 2031
Figure 03: Global Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivative Type, 2023–2031
Figure 04: Global Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application 2022 and 2031
Figure 05: Global Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031
Figure 06: Global Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031
Figure 07: Global Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031
Figure 08: Global Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Region, 2022 and 2031
Figure 09: Global Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Region, 2023–2031
Figure 10: North America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, 2017–2031
Figure 11: North America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Derivative Type, 2022 and 2031
Figure 12: North America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivative Type, 2023–2031
Figure 13: North America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031
Figure 14: North America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031
Figure 15: North America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031
Figure 16: North America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031
Figure 17: North America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country, 2022 and 2031
Figure 18: North America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country, 2023–2031
Figure 19: Europe Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, 2017–2031
Figure 20: Europe Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Derivative Type, 2022 and 2031
Figure 21: Europe Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivative Type, 2023–2031
Figure 22: Europe Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031
Figure 23: Europe Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031
Figure 24: Europe Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031
Figure 25: Europe Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031
Figure 26: Europe Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 27: Europe Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 28: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, 2017–2031
Figure 29: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Derivative Type, 2022 and 2031
Figure 30: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivative Type, 2023–2031
Figure 31: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application 2022 and 2031
Figure 32: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031
Figure 33: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031
Figure 34: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031
Figure 35: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 36: Asia Pacific Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 37: Latin America Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, 2017–2031
Figure 38: Latin America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Derivative Type, 2022 and 2031
Figure 39: Latin America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivative Type, 2023–2031
Figure 40: Latin America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031
Figure 41: Latin America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031
Figure 42: Latin America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031
Figure 43: Latin America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031
Figure 44: Latin America Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 45: Latin America Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 46: Middle East & Africa Bovine Blood Plasma Derivatives Market Value (US$ Mn) Forecast, 2017–2031
Figure 47: Middle East & Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Derivative Type, 2022 and 2031
Figure 48: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Derivative Type, 2023–2031
Figure 49: Middle East & Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031
Figure 50: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031
Figure 51: Middle East & Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Application, 2022 and 2031
Figure 52: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Application, 2023–2031
Figure 53: Middle East & Africa Bovine Blood Plasma Derivatives Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 54: Middle East & Africa Bovine Blood Plasma Derivatives Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 55: Global Africa Bovine Blood Plasma Derivatives Market Share Analysis, by Company, 2022
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Bovine Blood Plasma Derivatives Market
